ID: ALA2311206

Max Phase: Preclinical

Molecular Formula: C26H33N5O13P2

Molecular Weight: 685.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(C)c2c(c(O)c1C/C=C(\C)COP(=O)(O)CP(=O)(O)OC[C@@H]1O[C@H](n3cnc4c(N)ncnc43)[C@@H](O)[C@H]1O)C(=O)OC2

Standard InChI:  InChI=1S/C26H33N5O13P2/c1-12(4-5-14-19(32)17-15(7-41-26(17)35)13(2)22(14)40-3)6-42-45(36,37)11-46(38,39)43-8-16-20(33)21(34)25(44-16)31-10-30-18-23(27)28-9-29-24(18)31/h4,9-10,16,20-21,25,32-34H,5-8,11H2,1-3H3,(H,36,37)(H,38,39)(H2,27,28,29)/b12-4+/t16-,20-,21-,25-/m0/s1

Standard InChI Key:  MCYWJNDIVYMDSF-XDKQCGSTSA-N

Associated Targets(Human)

Inosine-5'-monophosphate dehydrogenase 1 221 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Inosine-5'-monophosphate dehydrogenase 2 1326 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

K562 73714 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 685.52Molecular Weight (Monoisotopic): 685.1550AlogP: 1.27#Rotatable Bonds: 12
Polar Surface Area: 268.13Molecular Species: ACIDHBA: 16HBD: 6
#RO5 Violations: 3HBA (Lipinski): 18HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.03CX Basic pKa: 4.92CX LogP: -2.35CX LogD: -4.55
Aromatic Rings: 3Heavy Atoms: 46QED Weighted: 0.09Np Likeness Score: 1.37

References

1. Pankiewicz KW, Lesiak-Watanabe KB, Watanabe KA, Patterson SE, Jayaram HN, Yalowitz JA, Miller MD, Seidman M, Majumdar A, Prehna G, Goldstein BM..  (2002)  Novel mycophenolic adenine bis(phosphonate) analogues as potential differentiation agents against human leukemia.,  45  (3): [PMID:11806722] [10.1021/jm0104116]
2. Rejman D, Olesiak M, Chen L, Patterson SE, Wilson D, Jayaram HN, Hedstrom L, Pankiewicz KW..  (2006)  Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.,  49  (16): [PMID:16884314] [10.1021/jm060479r]

Source